Drug Profile
Research programme: M3 muscarinic receptor antagonists - Chiesi Farmaceutici/SALVAT
Alternative Names: CHF-5407; SVT-47060Latest Information Update: 31 May 2010
Price :
$50
*
At a glance
- Originator SALVAT
- Class
- Mechanism of Action Muscarinic M3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Chronic obstructive pulmonary disease
Most Recent Events
- 02 Nov 2006 Preclinical trials in Chronic obstructive pulmonary disease (unspecified route)